Please Wait
Applying Filters...
menu
    • menu
    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-27

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    Menu

    Certepetide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lisata & Warpnine Show Encouraging Results For Certepetide In PDAC
    Lisata & Warpnine Show Encouraging Results For Certepetide In PDAC

    23 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/23/3014226/18623/en/Lisata-Therapeutics-and-WARPNINE-Announce-Encouraging-Preliminary-Results-from-the-Phase-1b-2a-iLSTA-Trial-Evaluating-Certepetide-in-Locally-Advanced-Non-Resectable-Pancreatic-Duct.html

    GLOBENEWSWIRE
    23 Jan 2025
    Share Share
    Lisata Therapeutics Reports Ph 2 Data On Certepetide For Cancer
    Lisata Therapeutics Reports Ph 2 Data On Certepetide For Cancer

    22 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/22/3013425/18623/en/Lisata-Therapeutics-Reports-Encouraging-Preliminary-Cohort-A-Data-from-the-AGITG-led-Phase-2-ASCEND-Trial-Evaluating-Certepetide-with-Standard-of-Care-Chemotherapy-in-Metastatic-Pa.html

    GLOBENEWSWIRE
    22 Jan 2025
    Share Share
    Lisata Signs Research Agreement on Certepetide for Endometriosis
    Lisata Signs Research Agreement on Certepetide for Endometriosis

    28 Oct 2024

    // #N/A

    https://www.globenewswire.com/news-release/2024/10/28/2970055/18623/en/Lisata-Therapeutics-Announces-Sponsored-Preclinical-Research-Agreement-with-the-University-of-Cincinnati-to-Study-Certepetide-for-the-Treatment-of-Endometriosis.html

    #N/A
    28 Oct 2024
    Share Share
    Lisata Therapeutics To Report Q2 2024 Results On August 12
    Lisata Therapeutics To Report Q2 2024 Results On August 12

    05 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/05/2924224/18623/en/Lisata-Therapeutics-to-Report-Second-Quarter-2024-Financial-Results-and-Provide-a-Business-Update-on-Monday-August-12-2024.html

    GLOBENEWSWIRE
    05 Aug 2024
    Share Share
    Lisata's Certepetide Shows Promise For Intrahepatic Cholangiocarcinoma
    Lisata's Certepetide Shows Promise For Intrahepatic Cholangiocarcinoma

    10 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/10/2911056/18623/en/Lisata-Therapeutics-Certepetide-Shows-Promise-in-Improving-Standard-Treatment-for-Intrahepatic-Cholangiocarcinoma-in-a-Preclinical-Model.html

    GLOBENEWSWIRE
    10 Jul 2024
    Share Share
    Lisata Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial
    Lisata Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial

    13 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/13/2898249/18623/en/Lisata-Therapeutics-Announces-Full-Enrollment-of-Pancreatic-Cancer-Cohort-of-CENDIFOX-Trial.html

    GLOBENEWSWIRE
    13 Jun 2024
    Share Share